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Abstract
Objectives To evaluate the accuracy of high-pitch delayed
enhancement (DE) CT for the assessment of myocardial
viability with MRI as the reference standard.
Methods Twenty-four patients (mean age 66.9±9.2 years)
with coronary artery disease underwent DE imaging with
128-slice dual-source CT (prospective electrocardiography
(ECG)-triggering) and MRI at 1.5 T. Two observers
assessed DE transmurality per segment, and measured
signal intensity (MRI) or attenuation (CT) in infarcted and
healthy myocardium and noise in the left ventricular blood
pool for calculating contrast-to-noise ratios (CNR).
Results 75/408 (18.4%) segments in 18/24 patients (75.0%)
showed DE in MRI, of which 28 segments in 10/24 (41.7%)
patients were non-viable (scar tissue transmurality >50%).
Sensitivity, specificity and accuracy of CT for diagnosis of
non-viability were 60.7%, 96.8% and 94.4% per segment, and
90.0%, 92.9% and 91.7% per patient. CNR was significantly
higher in MR (7.4±3.0 vs. 4.6±1.5; p=0.018), and image
noise significantly lower (11.6±5.7 vs.15.0±4.5; p=0.019).
Radiation dose of DECT was 0.89±0.07 mSv.
Conclusions CTDE imaging in the high-pitch mode ena-
bles myocardial viability assessment at a low radiation dose
and good accuracy compared with MR, although associated
with a lower CNR and higher noise.
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Introduction
The presence and transmural extent of myocardial infarc-
tion (MI) are important predictors of functional recovery of
myocardial contractility after surgical or interventional
revascularisation [1]. For the assessment of the transmural
extent of MI, delayed gadolinium enhancement with
cardiac magnetic resonance imaging (MRI) is considered
the gold standard [2]. Myocardial segments with >50%
transmural extent of delayed enhancement can be defined
as non-viable, as 90% of such segments show no
improvement in contractility after revascularisation [3].
Delayed enhancement imaging by MR is typically per-
formed 10–20 min after intravenous administration of
gadolinium-containing contrast material and is based on
the increased signal of infarcted myocardium compared
with remote healthy myocardial tissue. This enhancement is
caused by delayed wash-out kinetics of contrast material in
infarcted myocardium due to leakage into the interstitial
space caused by microvascular damage [4]. Similar
pharmacokinetics in infarcted myocardium also apply to
iodine-containing contrast materials used in catheter angi-
ography and computed tomography.
As a matter of fact, increased iodine concentration in
infarcted myocardial tissue after intravenous administration
of contrast material was described as early as 1978 with
computed tomography (CT) [5]. In recent years, delayed-
enhancement imaging of MI has repeatedly been evaluated
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using retrospectively electrocardiography (ECG)-gated
spiral CT, showing good concordance with delayed
enhancement MR imaging [6–8] and histology [9].
However, radiation dose associated with retrospectively
ECG-gated CT is within the range 4.5 mSv for a delayed-
enhancement 64-slice CT even when using a wider detector
collimation and low tube potential to reduce radiation
exposure [8]. This relatively high radiation dose is mainly
due to the low pitch values of 0.2–0.4 required for
retrospective ECG-gating. Recently, a prospectively ECG-
triggered high-pitch acquisition mode has been developed
for second-generation dual-source CT, enabling CT coro-
nary angiography (CTCA) at radiation doses below 1 mSv
[10–12]. This low radiation exposure is achieved by using a
high helical pitch enabling single-heartbeat cardiac data
acquisition with coverage of all axial slices that comprise
the heart in approximately 250 to 300 ms.
The purpose of this study was to evaluate the diagnostic
accuracy of DE CT in the high-pitch mode for the detection
of myocardial infarction and assessment of myocardial
viability with MRI as the standard of reference.
Materials and methods
Study population
From September 2009 until February 2010, 24 patients (22
men, age 66.9±9.2 years) with known coronary artery
disease, who were scheduled for coronary artery bypass
surgery (CABG), underwent both CT and MR imaging on
the same day for preoperative assessment of ischaemia and
for pre-operative planning. A detailed overview of patient
demographics is provided in Table 1. No beta-blockers
were administered immediately before imaging. However,
twenty of the 24 patients (83.3%) were on a baseline beta-
blocker medication. MR imaging was performed after CT
in all patients. Exclusion criteria for CT were: renal
dysfunction—defined as an estimated glomerular filtration
rate of less than 60 ml/min (n=1), hypersensitivity to
iodine-containing contrast media (n=0), untreated hyper-
thyroidism (n=0) and pregnancy (n=0). Exclusion criteria
for MRI were: incompatible metallic implants (n=1) and
claustrophobia (n=0). Atrial fibrillation (n=1) was an
exclusion criterion for both CT and MRI.
All patients provided written informed consent to
participate in this IRB-approved study.
CT data acquisition and image reconstruction
All CTs were performed on a 128-slice dual-source CT
system (Somatom Definition Flash, Siemens Healthcare,
Forchheim, Germany). First, a CTCA was obtained in the
high-pitch mode in patients with a heart rate (HR) <60 bpm,
or in a sequential mode with HR-adapted padding for
patients with HR >60 bpm. For this, 70 ml of iopromide
(Ultravist 370, 370 mg/ml, Bayer Schering Pharma, Berlin,
Germany) was injected through an 18 G catheter in a right
antecubital vein at a flow rate of 5 mL/sec followed by
40 mL of saline solution at the same flow rate. In order to
achieve an adequate dose of iodine for delayed enhancement,
5 min after the CTCA another 70 ml of iopromide (Ultravist
370, 370 mg/ml, Bayer Schering Pharma, Berlin, Germany)
was injected and the delayed enhancement CT was obtained
15 min after the first injection of contrast material, as
previously suggested [6]. As the findings from CTCA are
not the subject of this study, these results are not reported or
discussed further.
Delayed enhancement imaging was performed using an
ECG-synchronised dual-source high-pitch mode with the
following parameters: slice collimation 2×128×0.6 mm by
means of a z-flying focal spot; gantry rotation time 280 ms;
pitch 3.4; tube potential 100 kV; tube current–time product
320 mAs; field-of-view (FOV) 200×200 mm2 and matrix
512×512. CT data acquisition was initiated at the level of
the tracheal carina with a cranio-caudal direction beginning
in diastole at 60% of the RR interval as prospectively
determined by the patient’s ECG. The imaging range
extended to the apex of the heart. The heart rate during
data acquisition was noted.
Axial images were reconstructed with a slice thickness
of 1 mm and an increment of 0.7 mm, using a smooth tissue
convolution kernel (B10f). Identifying patient information
was removed from all images before they were transferred
to an external workstation (Multi-Modality Workplace,
Siemens Healthcare, Forchheim, Germany). Short-axis
thick-section (8 mm) multiplanar reformations covering
Table 1 Patient demographics
Demographic Statistic
Sex
Men 22
Women 2
Age (years) 66.9±9.2 (50.3–81.1)
Body mass index (BMI, kg/m2) 26.5±3.8 (19.5–35.7)
Cardiovascular risk profile
Arterial hypertension 20 (83.3%)
Nicotine abuse 11 (45.8%)
Hyperlipidaemia 18 (75%)
Diabetes mellitus 8 (33.3%)
Obesity (BMI>25 kg/m2) 14 (58.3%)
Positive family history 10 (41.7%)
Heart rate at CT (min−1) 55.8±8.4 (44–73)
Heart rate at MR (min−1) 57.7±9.5 (46–82)
2092 Eur Radiol (2011) 21:2091–2099
the entire myocardium of the left ventricle as well as each
vertical and horizontal long axis slice were generated by a
radiologist not involved in further image evaluation. The slice
thickness of 8 mm was chosen as previously described [6] to
correspond with the slice thickness used in MR imaging.
Radiation dose estimation
Effective radiation doses were estimated by multiplying the
dose-length product (DLP) obtained from the patient protocol
of each CT data acquisition with a conversion coefficient of
k=0.014 mSvmGy−1cm−1 as proposed by the European
Working Group for Guidelines on Quality Criteria in CT [13].
MR Data Acquisition and Image Reconstruction
All MRI was performed on a 1.5-Tesla system (Achieva,
Philips Medical Systems, Best, The Netherlands) with
dedicated cardiac phased-array receiver coils with five
elements used for signal reception. A standard clinical
cardiac MRI protocol including cine imaging, adenosine-
stress perfusion imaging and late gadolinium enhancement
imaging was used. A dose of 0.1 mmol/kg gadobutrolum
(Gadovist, Bayer-Schering Pharma, Germany) was injected
through an 18 G catheter into a right antecubital vein for
adenosine-stress perfusion imaging, followed by a further
dose of 0.1 mmol/kg of gadobutrolum 5 min thereafter for
rest imaging. Fifteen minutes after the first injection
delayed enhancement images were acquired in contiguous
short-axis slices covering the left ventricle as well as each
one vertical and horizontal long-axis slice using an
inversion-recovery gradient-recalled echo sequence with
the following parameters: repetition time 7.4 ms; echo time
4.3 ms; individually optimised inversion time of 200–
350 ms; flip angle 20°; FOV 400×400 mm2; matrix 320×
320 and a slice thickness 8 mm. Inversion times were
individually chosen based on the results of a Look-Locker
sequence for optimal myocardial signal nulling. Heart rates
during image acquisition were noted.
CT and MR data analysis
As our aim was to assess the accuracy of delayed
enhancement CT with a low-dose protocol in comparison
to delayed enhancement MRI as the standard of refer-
ence, only delayed enhancement acquisitions were eval-
uated for this study. Two independent radiologists (with
2 and 4 years of experience in cardiac imaging), who
were blinded to clinical data as well as to the results
from CTCA and other imaging results, assessed both CT
and MRI data for the presence and transmurality of
delayed enhancement using a 17-segment model de-
scribed by the American Heart Association [14]. Delayed
enhancement was graded as either present or absent and
delayed enhancement transmurality was assessed using a
five-point scale as previously described [3]: 0=0%; 1=1–
25%; 2=26–50%; 3=51–75% and 4=76–100% transmur-
ality. Diagnostic confidence was noted for each dataset on
a four-point scale as follows: 1=very high, 2=high, 3=
moderate and 4=low. For this subjective assessment,
window and center levels could manually be adjusted to
allow for optimal contrast settings.
Measurements of signal intensity (MR: arbitrary units,
AU) or attenuation (CT: Hounsfield units, HU) were
independently performed by both readers in regions of
interest (ROI) of approximately 30 mm2 each, covering
delayed enhancement, if present (ROIscar), within an ROI
covering normal-appearing remote myocardial tissue
(ROImyo) and within an ROI covering the blood pool of
the left ventricle (ROILV).
Image noise was defined as the standard deviation of signal
intensity within ROILV as previously described [7]. Contrast-
to-noise ratios (CNR) were calculated as scar-myocardium
(CNRmyo=(ROIscar - ROImyo)/noise) and scar–LV blood pool
(CNRLV (ROIscar – ROILV)/noise) CNR.
CT and MR images were evaluated in random order
with a time interval of 4 weeks between reading sessions
for each technique to minimise potential recall bias.
Disagreements regarding the presence and transmurality
of delayed enhancement in each segment were resolved in
a separate consensus reading for each technique.
Statistical analyses
Quantitative data are expressed as mean ± standard
deviation (range) and categorical data as proportions or
percentages.
Interobserver agreements regarding signal intensity and
noise measurements were compared using the intraclass
correlation coefficient and Bland-Altman analysis. Statisti-
cal comparison of means of the values for scar-myocardium
signal intensity difference, scar-left ventricle blood pool
signal intensity difference, noise, CNR and patient heart
rate between the two acquisition techniques was performed
using two-tailed paired t-tests after normality testing with
the Kolmogorov-Smirnov test.
Diagnostic confidence scores for the evaluation of CT and
MR images were compared using the Wilcoxon signed ranks
test. In order to assess the influence of diagnostic confidence
on the accuracy of viability assessment, the correlation of
diagnostic confidence scores and the difference in trans-
murality assessment between CT and MRI were evaluated
using Spearman’s rank correlation coefficient.
Interobserver agreements regarding diagnostic confidence
scores and viability assessment, as well as agreements
between the two acquisition techniques regarding the detec-
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tion of delayed enhancement, the definition of non-viable
segments (defined as >50% delayed enhancement trans-
murality) and the more detailed assessment using the five-
point transmurality score were evaluated using Cohen’s kappa
(κ) statistics with the following interpretation of κ values: >
0.81: excellent agreement, 0.61–0.80: good, 0.41–0.60:
moderate, 0.21–0.40: fair, <0.20: poor agreement.
Sensitivity, specificity and accuracy of delayed enhance-
ment CT for the detection of MI as well as the definition of
non-viable segments (i.e. MI transmurality>50%) were
calculated from Chi-squared tables of contingency with
MRI serving as the standard of reference.
All statistical analyses were performed using commercially
available software (SPSS, release 17.0, SPSS Inc., Chicago, IL,
USA). Statistical significance was inferred at a p value<0.05.
Results
All patients underwent CT and MRI without adverse
effects. HR were similar delayed enhancement imaging with
CT (55.8±8.4 min−1) and MRI (57.7±9.5 min−1, p=0.11).
Signal intensity, image noise and CNR
Interobserver agreements were excellent for measurements of
scar-, myocardial- and LV- signal intensity (MRI) or attenu-
ation (CT) as well as for image noise in bothMRI and CT data
(r=0.859–0.996; p each<0.001), with no significant differ-
ences between the measurements of the two observers
(p>0.05, each; Table 2). Thus the mean of both observers’
measurements was used for further calculations.
Signal intensity in areas of delayed enhancement was
significantly higher than in normal myocardium for both MRI
(109.4±29.9 AU vs. 6.2±4.3 AU; p<0.001) and CT (131.7±
15.8 HU vs. 66.8±9.6 HU). Compared with CT, MR images
showed significantly higher scar-myocardium signal intensity
difference (103.2±28.9 AU vs. 64.9±11.3 HU, p<0.001),
scar-LV blood pool signal intensity difference (33.3±
21.3 AU vs. 17.9±16.6 HU, p=0.017), CNRmyo (7.4±3.0
vs. 4.6±1.5, p=0.018) and CNRLV (3.3±2.1 vs. 1.2±1.1,
p=0.001) whereas image noise was significantly lower (MR:
11.6±5.7; CT: 15.0±4.5; p=0.019; Fig. 1).
Diagnostic confidence
Interobserver agreements regarding diagnostic confidence
were good for MRI (κ=0.662) and CT (κ=0.616).
Diagnostic confidence was very high in 16/24 (66.7%),
high in 7/24 (29.2%) and moderate in 1/24 (4.1%) for MR
images, whereas for CT images it was very high in 7
(29.2%), high in 12/24 (50.0%), moderate in 4/24 (16.7%)
and low in 1/24 (4.1%). Low diagnostic confidence was
attributed by both observers to one patient with non-
evaluable inferior segments due to streak artefacts. Mean
diagnostic confidence was significantly lower for CT
compared with MR (1.4±0.6 vs. 2.0±0.8; p=0.003).
Diagnostic confidence at CT was associated with
diagnostic accuracy: diagnostic confidence at CT showed
a moderate significant correlation with the difference
between CT and MR transmurality scores per patient, with
a decrease in diagnostic confidence being associated with
an increase in differences in the transmurality assessment
between CT and MRI (ρ=0.441; p=0.03).
Scar detection and transmurality assessment
Interobserver agreements for the assessment of myocardial
viability per segment were excellent for MRI (κ=0.871)
and good for CT (κ=0.776).
Seventy-five of the 408 (18.4%) segments in 18/24 patients
(75.0%) showed delayed enhancement at MRI, of which 28
segments (37.3%) in 10/24 patients (41.7%) were determined
to be non-viable (i.e. scar tissue transmurality >50%). Delayed
enhancement CT correctly identified 59/75 (78.6%) segments
with myocardial delayed enhancement and 17/28 (60.7%) non-
viable segments in 9/10 (90.0%) patients (Figs. 2 and 3).
Agreement between CT and MRI for the detection of delayed
enhancement was good (κ=0.757). A detailed overview of
transmurality scores in CT and MR is provided in Table 3.
Table 2 Interobserver agreements with delayed enhancement MRI and CT
MRI CT
Mean difference (± SD) Intraclass correlation Mean difference (± SD) Intraclass correlation
Delayed enhancement (scar) signal (MR)
or attenuation (CT)
0.02±5.69 AU; p=0.99 r=0.983; p<0.001 0.44±2.50 HU; p=0.12 r=0.933; p<0.001
Normal myocardium signal (MR) or
attenuation (CT)
0.21±2.41 AU; p=0.72 r=0.859; p<0.001 0.57±3.49 HU; p=0.50 r=0.938; p<0.001
Left ventricle (LV) blood pool signal
(MR) or attenuation (CT)
−0.41±2.15 AU; p=0.43 r=0.996; p<0.001 −0.14±2.54 HU; p=0.81 r=0.993; p<0.001
Noise (standard deviation of LV blood
pool signal [MRI] or attenuation [CT])
−0.01±0.86; p=0.99 r=0.989; p<0.001 −0.07±0.55 HU; p=0.61 r=0.993; p<0.001
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With MRI serving as the reference standard the
sensitivity, specificity and accuracy of CT were 78.7%,
96.4% and 93.1% for the detection of delayed enhancement
per segment and 60.7%, 96.8% and 94.4% for the
identification of non-viable segments, respectively. On a
per-patient basis sensitivity, specificity and accuracy for the
identification of patients with at least one segment showing
delayed enhancement were 100%, 83.3% and 95.8% and
90%, 92.9% and 91.7% for the identification of patients
with at least one non-viable segment, respectively (Table 4).
False-positive findings regarding the presence of delayed
enhancement in CTwere found in the lateral wall (segments
5, 6, 11, 12 or 16) in 9/12 (75%) and in the anterior wall
(segments 1, 7, 13) in 3/12 (25%) segments. No false-
positive findings occurred in septal or inferior segments.
False negative findings occurred in the inferior wall
(segments 3, 4, 5, 9, 10, 11, 15) in 11/16 (68.8%) and the
lateral wall in 5/16 (31.2%). No false negative findings
occurred in the anteroseptal or anterior segments.
Radiation dose estimation
The CT dose index (CTDIvol) of the delayed enhancement
CT imaging protocol was 3.10 mGy. Mean DLP was 63.6±
5.2 mGycm (range: 53–73 mGycm) with a resulting
estimated effective radiation dose of 0.89±0.07 mSv
(range: 0.74–1.02 mSv).
Discussion
Our results indicate that myocardial delayed enhancement
imaging with CT using a prospectively ECG-triggered
high-pitch mode is feasible in patients with coronary artery
Fig. 1 Box plots (boxes: interquartile ranges, whiskers: ranges)
showing image noise (a) and contrast-to-noise ratios (CNR) of scar–
myocardium contrast (b) and scar–left ventricular blood pool contrast
(c) with delayed enhancement magnetic resonance imaging (MRI) and
computed tomography (CT)
Fig. 2 Delayed enhancement imaging with MRI (upper row) and CT (lower row) in a 74-year-old patient with known occlusion of the distal
right coronary artery showing transmural delayed enhancement in basal and midventricular segments (arrowheads)
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disease and enables the diagnosis of MI as well as
myocardial viability assessment with good diagnostic
accuracy at a low radiation dose, although being associated
with a lower CNR and higher image noise compared with
the reference standard of MRI.
Delayed enhancement CT for the assessment of myocar-
dial viability in comparison to MR imaging has previously
been evaluated using 16-slice [7, 8] and 64-slice CT [9, 12].
Agreement regarding the presence of delayed enhancement
in CT and MRI on a per-segment basis was reported to be
good (κ=0.610–0.878) [7, 8]. The agreement found in our
study (κ=0.757) is in line with these previous reports. Using
MRI as the reference standard, we found a high diagnostic
accuracy of CT for the detection of non-viable segments, i.e.
segments showing >50% transmurality of delayed enhance-
ment when using the low-dose technique operated with a
high pitch. Our results are comparable to the sensitivity,
specificity and accuracy of 84%, 96%, 94%, per segment
and of 90%, 80%, 88%, per patient for the assessment of
myocardial viability reported in a study evaluating delayed
enhancement CT following catheter coronary angiography
[15]. A number of studies have also confirmed a good
correlation between infarct size as a percentage of myocar-
dial volume among delayed enhancement CT and MRI [6, 8,
16, 17].
The advantage of delayed enhancement CT over MRI is
that it would bemore widely available and could be performed
in patients with MR-incompatible metallic implants such as
pacemakers and implantable cardioverter-defibrillator devi-
ces. Furthermore, delayed enhancement imaging could be
integrated into a comprehensive assessment of coronary artery
disease by CT in a so-called “one-stop-shop” including CT
coronary angiography, global and regional LV functional
assessment [18, 19] and delayed enhancement imaging. In a
pilot study it was recently shown that co-registration of
CTCA and CTDE images enables the identification of the
culprit vessel in MI beyond the segmental model approach
[20]. However, there are some limitations of delayed
enhancement CT imaging, hindering its widespread use for
the assessment of myocardial viability.
One disadvantage of delayed enhancement CT is the
significantly lower contrast-to-noise ratio compared with
MRI. This can be explained by the different concept of
signal/attenuation between the techniques. Although the
pharmacokinetics of contrast media containing iodine and
gadolinium are similar, delayed enhancement at CT is based
on the high density and atomic number of iodine, whereas
Fig. 3 Delayed enhancement imaging with MRI (upper row) and CT (lower row) in a 52-year-old patient with known occlusion of the mid-left
anterior descending artery showing non-transmural delayed enhancement in the midventricular segments (arrowheads)
Table 3 Transmurality scores with delayed enhancement MRI and
CT
CTa Total
0 1 2 3 4
MRa 0 321 2 5 5 0 333
1 5 5 5 1 0 16
2 7 3 15 6 0 31
3 2 0 6 9 3 20
4 2 0 1 2 3 8
Total 337 10 32 23 6 408
a Transmurality scores were defined as 0: no delayed enhancement
(0%), 1: 1–25%, 2: 26–50%, 3: 51–75% and 4: 76–100% trans-
murality of delayed enhancement.
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gadolinium used in MRI leads to shortening of relaxation
times. Delayed enhancement imaging in MRI is performed
using an inversion recovery technique with the inversion
time chosen to null the signal of normal myocardium,
resulting in a high difference between the signal of healthy
myocardium and the hyperintense signal of the infarcted,
non-viable myocardium accumulating gadolinium [21].
Particularly the significantly higher scar-LV blood pool
signal intensity differences of MRI compared to CT may
enable better delimitation of small subendocardial areas of
delayed enhancement. CT, on the other hand, is limited by
differences in density and atomic numbers between iodine
and tissue. Therefore, the use of low tube potentials (80 or
100 kV) is usually advocated for delayed enhancement
imaging with CT, making use of the higher attenuation of
iodine at lower photon energies [22, 23]. However, low
tube potentials may lead to unacceptable image noise levels
in obese patients.
In our study, lower CNR at CT was associated with a
lower diagnostic confidence, resulting in differences in
delayed enhancement transmurality scores between CT and
the reference standard MRI. It must be noted that CNR and
image noise are merely two objective parameters of image
quality and do not fully explain differences in subjective
conspicuity of lesions between CT and MRI. Low diagnos-
tic confidence was noted by both observers for one CT
dataset with non-evaluable inferior segments because of
streak artefacts, presumably caused by the liver (see Fig. 4).
These non-evaluable segments were rated as false-negatives
in an intention-to-diagnose approach. The deterioration of
image quality in delayed enhancement CT by streak
artefacts due to attenuation of the x-ray beam by the liver
has previously been described [8] and may be reflected by
the finding that false-negative segments regarding the
presence of delayed enhancement were predominantly
found in the inferior wall, whereas false-positive high
attenuation findings predominantly occurred in the lateral
wall, adjacent to the low-attenuating lung parenchyma.
A further limitation of CT delayed enhancement imaging
is the necessity of relatively large volumes of contrast
material, again caused by the issue of low CNR [24]. We
used a protocol administering a total of 140 ml of contrast
material with an iodine concentration of 370 mg/ml
separated into two doses at 15 and 10 min before delayed
enhancement imaging. The use of such a protocol with two
separate boli has previously been reported to be feasible,
showing good correlations between CT and MRI [16].
Currently, there is no consensus regarding the optimal
protocol for contrast material administration and timing of
delayed enhancement imaging with CT. Contrast material
volumes of 120–150 ml and delay times from 5 [9] to
15 min [6] have been previously suggested. Using a dose of
Table 4 Diagnostic accuracy of delayed enhancement CT with MRI as the standard of reference
TP TN FP FN Sensitivity (%) Specificity (%) Accuracy (%)
Segments (n=408) Delayed enhancement present 59 321 12 16 78.7 (67.7–87.3) 96.4 (93.8–98.1) 93.1 (90.2–95.4)
Delayed enhancement
transmurality >50%
17 368 12 11 60.7 (40.6–78.5) 96.8 (94.6–98.4) 94.4 (91.7–96.4)
Patients (n=24) Delayed enhancement present 18 5 1 0 100 (81.5–100) 83.3 (35.9–99.6) 95.8 (78.9–99.9)
Delayed enhancement
transmurality >50%
9 13 1 1 90 (55.5–99.8) 92.9 (66.1–99.8) 91.7 (73.0–99.0)
TP: true-positives, TN: true-negatives, FP: false-positives, FN: false-negatives. Values are given as percentages with 95% confidence intervals in
parentheses.
Fig. 4 Delayed enhancement
imaging withMRI (a) and CT (b)
in a 73-year-old patient with
known occlusion of the mid-right
coronary artery. MRI enabled the
diagnosis of a transmural inferior
scar (arrowheads in a) with high
diagnostic confidence. Low
diagnostic confidence was
attributed to the CT image
because of the beam hardening
artefacts presumably caused by
the liver (arrows in b); the
diagnosis was consequently
missed
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2 ml/kg of iodine-containing contrast media it has been
shown that CNR between infarcted and healthy myocardi-
um in pigs was significantly higher than that of remote
normal myocardium starting at 4 min after injection of and
remained stable until 20 min after injection, after which it
decreased rapidly [7]. These results suggest that delayed
enhancement imaging should be performed between 4 and
20 min after contrast material injection. Furthermore, the
use of a protocol consisting an initial contrast bolus
followed by a low-flow contrast infusion during the
following 5 minutes has been reported to result in an
increase of scar-LV blood pool attenuation differences [23],
which were significantly lower for CT compared to MRI in
our study.
Finally, radiation doses associated with CT are a matter
of continuous concern. For delayed enhancement CT
imaging, doses of 2.4 mSv–3.8 mSv for 16-slice [6, 7]
and 3.8 mSv–4.5 mSv for 64-slice CT [8, 15, 16] were
reported. Our results demonstrate that by using a prospec-
tively ECG-triggered high-pitch acquisition mode on a 128-
slice dual-source CT, delayed enhancement imaging is
feasible with CT at low effective radiation doses of less
than 1 mSv.
The study had some limitations. First, our study
population consisted of patients with known coronary
artery disease, scheduled to undergo CABG surgery and
therefore showed a high prevalence of segments with
delayed enhancement. Unlike sensitivity and specificity,
diagnostic accuracy is affected by the prevalence of
disease and may therefore be different in a population
with a low prevalence of myocardial infarction. Further-
more, because the baseline medication with beta blockers
was used in 83% of the patients, the mean heart rate of
the study population was remarkably low. At high heart
rates motion artefacts are known to deteriorate image
quality of the coronary arteries when using diastolic high-
pitch acquisition protocols [25], and although delayed
enhancement imaging of the myocardium would not be
expected to be as susceptible to motion artefacts as
coronary imaging, our results may not be directly transfer-
able to a population with higher heart rates.
Conclusions
Delayed enhancement imaging by CT can be considered a
valuable alternative for patients with contraindications for
MR imaging, although it has its limitations caused by low
CNR, the necessity for high volumes of contrast material
and its association with ionising radiation. Nevertheless,
when using a prospectively ECG-triggered high-pitch data
acquisition mode, delayed enhancement imaging is feasible
at a very low radiation dose of less than 1 mSv with high
diagnostic accuracy for the diagnosis of MI as well as
myocardial viability assessment in patients with coronary
artery disease.
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